SequelSEC

AETERNUM HEALTH, INC. AETN

Miscellaneous Electrical Machinery, Equipment & Supplies · CIK 0000764630 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$203.66K
Fiscal year ended 2025-12-31
Operating income
-$269.27K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

AETERNUM HEALTH, INC. (AETN) reported revenue of $203.66K and net income of -$337.09K for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from AETERNUM HEALTH, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Electrical Machinery, Equipment & Supplies.

Income

AETERNUM HEALTH, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312024-02-292023-12-312023-02-282022-02-282018-02-282017-02-282016-02-292015-02-28
Revenue$203.66K$65.12K$19.61K$20.11K$22.28K$5.00K$0$0$0$13.94K
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profit$120.05K-$12.70KUnavailable-$33.02KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$269.27K-$430.49K-$584.24K-$552.36K-$258.52K-$304.04K-$48.96K-$59.87K-$81.43K-$83.61K
Net income-$337.09K-$450.32K-$661.96K-$632.95K-$315.52K-$2.07M-$52.50K-$61.12K-$83.23K$103.63K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 49.05Mshares 48.48Mshares 48.14Mshares 42.48Mshares 47.13Mshares 5.75Mshares 3.51Mshares 3.51Mshares 3.51Mshares 4.62M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailable$0UnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.01$-0.01$-0.01$-0.01$-0.01$-0.36$-0.01$-0.02$-0.02$0.02
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$105.26K$99.80K$104.59K$335.49K$47.48K$229.48KUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

AETERNUM HEALTH, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312024-02-292023-12-312023-02-282022-02-282018-02-282017-02-282016-02-292015-02-28
Cash & equivalents$0$0$0$0$0$0$330$280$416$614
Total assets$54.56K$65.42K$209.38K$308.50K$676.27K$212.96K$330$280$416$614
Current assets$53.56K$64.42K$208.38K$307.50K$675.27KUnavailable$330$280$416$614
Total liabilities$2.05M$1.74M$1.52M$1.53M$1.52M$13.48K$2.31M$2.25M$2.19M$2.11M
Current liabilities$1.13M$821.76K$524.90K$501.28K$358.42K$13.48K$2.31M$2.25M$2.19M$2.11M
Total equity incl. NCI-$2.00M-$1.68M-$1.31M-$1.23M-$846.52K-$1.60M-$2.31M-$2.25M-$2.19M-$2.11M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$37.20K$44.76K$7.36K$6.88K$6.88KUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$984$0Unavailable$0$50.00KUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$48.86KUnavailableUnavailableUnavailableUnavailable$13.48KUnavailableUnavailableUnavailableUnavailable

Cash flow

AETERNUM HEALTH, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312024-02-292023-12-312023-02-282022-02-282018-02-282017-02-282016-02-292015-02-28
Operating cash flow-$2.96K-$154.05K-$341.61K-$267.03K-$303.33K-$117.99K-$38.04K-$41.05K-$45.98KUnavailable
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailable-$50.00K$0$0$0$0Unavailable
Financing cash flowUnavailable-$113.24K-$149.16K$547.14K$651.20K$298.67K$38.08K$40.92K$45.78KUnavailable
Net change in cash-$2.96K-$267.29K-$490.76K$280.11K$347.87K$180.68K$50-$136-$198-$10.36K
Stock-based compensation$14.23KUnavailableUnavailable$197.84KUnavailable$88.75KUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

AETERNUM HEALTH, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312024-02-292023-12-312023-02-282022-02-282018-02-282017-02-282016-02-292015-02-28
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin58.9%-19.5%-181.9%-164.2%-104.3%UnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-132.2%-661.1%-2979.3%-2746.8%-1160.3%-6080.7%UnavailableUnavailableUnavailable-599.8%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue7.0%UnavailableUnavailable983.9%Unavailable1775.0%UnavailableUnavailableUnavailableUnavailable
Current ratio0.05x0.08x0.40x0.61x1.88xUnavailable0.00x0.00x0.00x0.00x
Revenue YoY growth212.7%UnavailableUnavailableUnavailable345.6%UnavailableUnavailableUnavailable-100.0%Unavailable
Net margin-165.5%-691.5%-3375.7%-3147.6%-1416.1%-41467.8%UnavailableUnavailableUnavailable743.4%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AETN in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-05-19View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-K/A · Filed 2025-09-03View SEC filing
10-Q · Filed 2025-08-19View SEC filing

Companies in the same industry

ADNH AMPX ATKR AUSI BEEM BLNK BURU BYRN CETI CHPT DFLI EMAT

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-02-29

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-02-28

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

balance equationreview2022-02-28

Difference 1795483 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.